Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod (Aldara) in cancer-related skin lesions
2004-002526-22Phase 4Completed
- Sponsor
- Cima Universidad de Navarra
- Start
- Mar 2012
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of imiquimod in cancer-related skin disease, sponsored by Cima Universidad de Navarra. Started Mar 2012; status: completed.
02
Drugs
imiquimod
03
Conditions
cancer-related skin disease
Beyond the preview
Go deeper on 2004-002526-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002526-22.